Article Listing - More than 220 medicines in US pipeline for diabetes

INDIA; DRUG REVIEW DELAYS POLICY

3 February 1992

A new review of the drug products which are to remain under government price control is reportedly causing delay in...

PROTEUS INTERNATIONAL "PROCEEDING TO PLAN"

3 February 1992

The six months to September 1991 saw continuing developments for UK computer-aided molecular modelling and drug design company Proteus International....

HOECHST ATTACKED OVER MIFEPRISTONE

3 February 1992

Hoechst Celanese Corp, a US subsidiary of Hoechst-AG, one of the companies behind the manufacturers of the controversial abortifacient drug...

ROBERTS' SOMAGARD APPROVED IN EIRE

3 February 1992

Roberts Pharmaceutical Corporation has been granted marketing approval by the Republic of Ireland's regulatory authorities for its prostate cancer treatment...

VESTAR'S AMBISOME LAUNCHED IN THE UK

3 February 1992

The first liposomal formulation of a drug has now been launched in the UK, in the form of Vestar's Ambisome,...

ENZON AND ALLELIX IN EGF DEAL

3 February 1992

Enzon has signed an agreement with Allelix Biopharmaceuticals for the development of a modified version of epidermal growth factor, using...

STOCK MARKET COMMENTARY: EUROPE

3 February 1992

EUROPE: saw ups and downs on the reporting week, with Belgium, Germany and Switzerland the strongest stock markets. FRANKFURT saw...

GOOD 1991 RESULTS FOR MERCK AND FOREST LABS

3 February 1992

Fourth quarter and 1991 year-end financial results announced in the USA over the past week were led by the generics...

APPOINTMENTS AT BRISTOL-MYERS SQUIBB

3 February 1992

- At Bristol-Myers Squibb Co, Wesley Thompson has been appointed president of the Bristol-Myers Squibb Consumer Products International division....

FOREST LAB'S ROBIN BURROWS RETIRES

3 February 1992

- Robin Burrows has resigned as vice president of corporate development with Forest Labor-atories Inc, and is presently acting as...

Showing 94841-94850 of 95329 articles